1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil structure
|
Common Name | 1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil | ||
|---|---|---|---|---|
| CAS Number | 2072145-82-3 | Molecular Weight | 500.54 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H28N2O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-(5-O-Methoxytrityl-2-deoxy--D-xylofuranosyl)uracil |
|---|
| Description | 1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H28N2O6 |
|---|---|
| Molecular Weight | 500.54 |
| InChIKey | OGNWBRYGAKIEJL-RGSZASNESA-N |
| SMILES | COc1ccc(C(OCC2OC(n3ccc(=O)[nH]c3=O)CC2O)(c2ccccc2)c2ccccc2)cc1 |